Gene Query: RARG

Dataset Description Geneva Score
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 37.53
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 37.53
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 36.79
Subtle asymmetry of gene expression in embryonic and foetal human brains 31.25
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 28.05
Gene expression analysis of the impact of TDP-43 knockout in human cells. 27.48
Silencing SPIB in attached and floating state of H1703 lung cancer cells 27.33
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 26.82
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 26.48
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 26.48
TFAP2C signalling in human fibroblasts 26.15
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 25.3
ARID1A and ARID1B loss in HCT116 cells 24.77
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 24.33
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 23.92
RNA-Seq from early time points in the kidney differentiation protocol 23.56
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 23.55
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 22.64
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 22.15
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 21.79
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 21.38
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 20.87
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 20.86
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 20.63
Conservative alteration of chromosomal expression pattern across human solid tumor types 20.54
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 20.2
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 20.1
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 20.1
Nutritional control of protein translation 20.04
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 19.98
Energy Metabolism during Anchorage-Independence 19.8
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 19.58
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 19.58
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 18.66
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 18.66
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 18.64
NR2F2 study 18.47
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 18.47
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 17.98
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 17.89
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 17.59
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 17.54
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 17.41
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 16.73
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 16.07
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 15.61
Transcriptome analysis of U87 cells upon LINC00152 knockdown 15.42
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 15.39
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 15.39
Active translatome profiling with RiboLace in MCF7 cells 15.37
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 15.32
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 15.32
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 15.2
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 15.1
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 15.1
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 14.97
Maturation of human iNSCs 14.93
Functional role of SLIT2 and ROBO1 in trophoblasts 14.77
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 14.71
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 14.7
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 14.67
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 14.52
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 14.5
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 14.27
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 14.17
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 14.17
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 14.14
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 14.14
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 13.9
RNA-seq differential expression studies: more sequence, or more replication? 13.89
High level DNA repair gene expression in human ES cells 13.83
RNA-seq analyisis of PUM2 knockout cells 13.81
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 13.77
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 13.76
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 13.63
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 13.63
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 13.58
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 13.53
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 13.33
Identification of global regulators of T-helper cell lineage specification 13.33
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 13.29
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 13.04
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 13.02
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 12.95
DIGIT regulates endoderm differentiation of human embryonic stem cells 12.89
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 12.71
Generation of trichogenic adipose-derived stem cells by expression of three factors 12.48
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 12.47
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 12.47
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 12.43
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 12.32
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 12.23
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 12.2
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 12.17
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 12.17
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 12.16
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 12.14
ARID1A and ARID1B loss in HCT116 and TOV21G cells 12.08
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 11.92
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 11.72
Transcriptional responses of melanoma cells to BRAF inhibition 11.62
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 11.43
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 11.41
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 11.34
Silencing p300 in MCF7 cells to study expression and alternative splicing 11.34
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 11.33
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 11.19
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 11.19
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 11.17
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 11.09
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 10.89
IRF2 is a master regulator of human keratinocyte stem cell fate 10.89
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 10.71
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 10.6
RNA sequencing analysis of human embryonic stem cells and axial progenitors 10.57
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 10.55
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 10.55
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 10.54
Tumor exosome integrins determine organotropic metastasis 10.51
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 10.5
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 10.44
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 10.44
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 10.11
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 10.06
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 10.05
Transcriptional profiling of LS1034 cells treated with tepoxalin 9.98
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 9.94
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 9.94
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 9.92
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.78
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 9.76
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 9.71
Retinoic acid suppresses MYB in adenoid cystic carcinoma 9.71
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 9.68
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 9.67
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 9.67
Human embryonic stem cells in E8 and AKIT culture medium 9.67
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 9.62
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 9.62
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 9.61
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 9.61
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 9.6
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 9.45
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 9.45
RNA-seq of human fibroblasts after irradiation 9.39
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 9.31
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 9.3
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 9.29
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 9.21
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 9.2
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 9.0
Regulation of Lipids is Central to Replicative Senescence 8.98
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 8.98
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 8.98
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 8.94
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 8.94
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 8.93
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 8.93
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 8.84
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 8.8
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 8.8
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 8.7
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 8.7
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 8.57
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 8.51
Characterization of parental and rociletinib-resistant derived H1975 cell lines 8.49
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 8.48
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 8.46
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 8.38
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.33
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 8.3
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 8.25
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 8.25
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 8.18
Genome-wide chromatin analysis of Ewing sarcoma 8.1
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 8.1
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 8.06
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 8.05
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 8.02
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 7.98
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 7.96
H1609088 Human RNA-Sequencing 7.95
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.92
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.91
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 7.91
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 7.91
Fbxo32 mediated gene expression program underlies EMT and metastasis 7.88
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 7.86
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 7.86
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 7.85
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 7.82
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 7.77
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 7.77
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 7.67
G-quadruplex structures mark human regulatory chromatin 7.66
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 7.65
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 7.59
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 7.59
circRNA profile in hypopharyngeal cancer 7.57
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 7.55
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.52
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 7.52
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 7.42
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 7.41
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 7.4
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 7.39
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 7.38
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 7.32
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 7.31
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 7.28
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 7.22
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 7.22
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 7.17
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 7.13
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 7.12
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 7.07
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 7.05
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 7.05
RNA-seq analysis of BAP1-depleted uveal melanoma cells 6.99
Next Generation Sequencing of human SMA and healthy control Motor Neurons 6.98
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 6.93
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 6.88
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 6.84
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 6.83
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 6.83
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.81
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.81
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.79
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 6.78
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.78
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 6.77
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.77
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.77
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.7
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.7
Survival of pancreatic cancer cells lacking KRAS function 6.7
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 6.69
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.65
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.65
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 6.6
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 6.59
RNA-sequencing in immortalized human mammary epithelial cells 6.58
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 6.58
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.57
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 6.56
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 6.51
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 6.48
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 6.43
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 6.43
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 6.42
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 6.39
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 6.39
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 6.39
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.38
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 6.36
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 6.36
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 6.36
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 6.33
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 6.33
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 6.3
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 6.29
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.23
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.23
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 6.22
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 6.2
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 6.18
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 6.18
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 6.16
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 6.16
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 6.11
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 6.1
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 6.09
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 6.07
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 6.07
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.05
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 6.04
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 6.03
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 6.02
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 6.0
The cytokine environment influence on human skin-derived T cells 5.97
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 5.97
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 5.94
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 5.94
Gene expression changes in human melanoma cell lines compared to primary melanocytes 5.91
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 5.91
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 5.9
MAIT cell RNA sequencing 5.87
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 5.83
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 5.8
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 5.8
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 5.78
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 5.73
m6A-dependent regulation of messenger RNA stability 5.73
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 5.71
Nonpregnant and term pregnant human myometrial tissues 5.71
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 5.7
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 5.68
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.65
RNA seq analysis of human Fetal and adult derived Enterospheres 5.63
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 5.59
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 5.56
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 5.56
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 5.51
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 5.49
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 5.44
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.43
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 5.42
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 5.38
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 5.35
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 5.35
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 5.33
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 5.33
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 5.28
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 5.18
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.12
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 5.09
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 5.06
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 5.04
Expression profiling of MCF-7 cells with treatment of TCDD 5.04
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 5.04
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 5.03
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 5.0
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 4.92
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 4.88
Characterization of human ILC2 subsets 4.84
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.84
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 4.83
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 4.83
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 4.82
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 4.82
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.81
RNA sequencing of human mammary epithelial cells 4.75
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 4.71
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 4.71
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 4.69
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 4.69
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 4.64
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 4.64
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.62
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.62
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 4.55
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 4.55
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 4.55
Transcriptome of activated human and mouse MAIT cells 4.47
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.37
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.34
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.34
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 4.32
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 4.31
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 4.2
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 4.19
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 4.19
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 4.19
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 4.18
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 4.18
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 4.15
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 4.15
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.11
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 4.09
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 4.03
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.0
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 3.97
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.96
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 3.96
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 3.96
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 3.96
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 3.96
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.93
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 3.91
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 3.9
RNA-Seq of PRMT1 overexpression ECA109 cells 3.86
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.83
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.83
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.63
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 3.57
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.52
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 3.42
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 3.42
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 3.4
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.39
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 3.38
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 3.36
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 3.3
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 3.26
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.26
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 3.19
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 3.12
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 3.06
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 3.06
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 2.98
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 2.98
Interaction between mitoNEET and NAF-1 in cancer cells 2.96
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 2.96
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 2.93
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 2.91
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.88
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 2.88
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 2.86
Differential gene expression of human melanoma cells [RNA-seq] 2.86
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.83
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 2.78
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.77
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 2.71
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.71
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.68
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.66
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.6
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 2.59
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.57
RNA editing in nascent RNA affects pre-mRNA splicing 2.53
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.51
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 2.49
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.45
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 2.38
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.25
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.22
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 2.17
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.15
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.15
Aneuploidy-induced cellular stresses limit autophagic degradation. 2.09
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.08
The circadian transcriptional landscape in primary human mammary epithelial cells 2.07
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 2.06
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.01
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.91
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.91
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 1.91
Differential gene expression in Jagged1 treated human dental pulp cells. 1.89
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.87
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.82
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.82
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 1.75
Expression profiling of converted and control dermal BJ fibroblasts 1.75
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 1.75
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.74
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.74
mRNA sequencing of oropharyngeal cancer cell lines 1.63
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.55
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 1.48
Positively selected enhancer elements endow tumor cells with metastatic competence 1.47
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.47
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.47
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.44
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 1.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.4
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.4
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.38
Metabolism as an early predictor of DPSCs aging 1.33
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.23
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 1.19
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 1.19
Illumina Total RNA-seq in HeLa 1.18
Gene expression analysis of breast cancer cell-lines 1.14
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.14
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.13
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.13
mRNA differential expression analysis in a human ex vivo model of chronic wounds 1.11
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.09
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 1.07
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.06
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.06
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.04
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.98
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 0.96
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 0.96
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.92
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.91
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.91
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.91
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.9
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.87
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.84
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.76
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.75
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.74
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.74
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 0.69
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.68
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.67
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.63
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.6
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.56
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.56
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.52
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.5
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.46
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.36
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.33
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.33
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.32
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.3
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.28
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 0.28
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 0.28
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.26
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.24
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.21
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.05
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.01
Gene expression profile of CRC-derived HILEC 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation